CEO Watcher

Consider buying Summit Therapeutics (SMMT), as two co-CEOs each purchased $6 million worth of stock following a recent 27% price decline. Similarly, four top executives at Envestnet (ENV) are buying shares for the first time in over two years, suggesting they see value after a 30% drop in the last year. Conversely, the CEO of LSI Industries (LYTS) made his first-ever discretionary sale after a price pop, indicating a potential near-term top. The co-CEOs at Ichor Holdings (ICHR) are also making their first-ever sales after a large run-up, signaling the stock may be overvalued. Finally, heavy insider selling at LoanDepot (LDI) and Carvana (CVNA) suggests management is cashing out on recent price surges, raising caution about their current valuations.

A director at Highcroft Mining made their first-ever stock purchases, investing a massive $60 million over the last few months, signaling extreme insider confidence. In contrast, a Senior Vice President at Designer Brands (DBI) sold their entire personal stake after the stock rallied over 40%. Historically, this specific executive's sales have been followed by an average stock decline of 27%. Another strong bearish signal comes from Aeye Inc. (LIDR), where a director is consistently selling shares after a massive 350% run-up. This director's previous sales have preceded average stock drops of over 50%, indicating a high risk of a major correction.

Multiple top executives at Enovis (ENOV), including the CEO, recently made their first-ever open-market stock purchases, signaling strong internal conviction that the stock is undervalued. Consider AudioEye (AEYE) for a longer-term hold, as a director's recent large purchase follows a historical pattern of the stock gaining over 50% within six months. Investors should be cautious with Tango Therapeutics (TNGX), as a major shareholder's recent $5.1 million sale has historically been followed by an average stock price decline of 42% within three months. The CEO of GigaCloud Technology (GCT) just made his first-ever unscheduled stock sale, a potential red flag from an insider with a strong track record of selling before price drops. Keep an eye on Cure Oncology, as the CEO's first-ever stock purchases precede a critical FDA decision due by November 30th, creating a high-risk, high-reward scenario.

A director at Broadcom (AVGO) purchased $1.23 million in stock, a notable move given their last purchase in 2023 preceded a 300% gain. Consider the opportunity in Permafix Environmental (PESI), where a director bought shares after a debunked rumor caused a significant price drop, signaling a potential recovery. Conversely, the CTO of CleanSpark (CLSK) and the CEO of GigaCloud (GCT) both made their first-ever unscheduled sales, a significant red flag from insiders with strong track records of timing price peaks. The CLSK insider's previous sales have historically preceded an average stock decline of over 20% within three months. Caution is also warranted for Coursera (COUR), as multiple executives continue to sell shares following its recent earnings pop.

The CEO of Curis Oncology (CRIS) has made his first-ever stock purchases ahead of a major FDA ruling expected by November 30th, signaling high confidence in a positive outcome. For energy exposure, consider MDU Resources (MDU), where the CFO recently made his largest-ever buys and has a perfect one-year track record on previous purchases. A key insider at Pango Therapeutics (PGTX) is making their largest-ever sales after a 250% stock run-up, suggesting a potential price decline. In the housing sector, consider avoiding D.R. Horton (DHI) due to significant insider selling. Instead, research competitors like Resideo Technologies (REZI) and Builders FirstSource (BLDR), which are seeing insider buying.

A director at Broadcom (AVGO) with a strong track record just made a $1.23 million purchase, their first since 2023, signaling potential upside. Consider Permafix (PESI) as a potential "buy the dip" opportunity after a director purchased shares following a rumor-driven 20% price drop. Conversely, the CEO of GigaCloud (GCT) made his first-ever unscheduled stock sale, a significant warning sign given his history of well-timed sales before price drops. The CTO of CleanSpark (CLSK) also made his first-ever unscheduled sale, which was his largest on record. These unscheduled sales from key executives with a history of successful timing are strong warnings for investors in GCT and CLSK.

Consider buying Novocure (NVCR), as the CEO made her first-ever stock purchase and the CFO also bought in, signaling high conviction from top executives after a recent price drop. Another bullish opportunity is Netstreit (NTST), where the CEO, who has a history of successful buys, recently made his largest purchase ever. Conversely, a bearish signal has appeared in LoanDepot (LDI), where the CEO is aggressively increasing his stock sales immediately following the stock's recent 80% surge. Similarly, the Executive Chairman of Vital Farms (VITL) is showing urgency to sell after a large price increase, making both a massively increased scheduled sale and a large unscheduled sale. Lastly, a major institutional holder continues to heavily buy Galiano Gold (GAU) even as the price rises, suggesting strong belief in further upside.

An insider at CECO Environmental (CECE) with a 76% win rate is buying repeatedly, signaling potential short-term upside. For long-term investors, the CFO of MDU Resources (MDU) is buying, with their previous purchases averaging a 33% return over one year. Conversely, insiders at homebuilder DR Horton (DHI) and Vertiv Holdings (VRT) are selling heavily after large rallies, suggesting these stocks may have peaked. A major owner of Tango Therapeutics (TNGX) just sold shares, an action that has historically preceded an average 40% stock decline. Finally, Cura Oncology is a high-risk, high-reward opportunity, as the CEO is buying aggressively ahead of a critical FDA drug decision expected by November 30th.

Multiple insiders at The Cooper Companies (COO) are engaging in cluster buying, a very bullish signal led by a CEO with a strong track record of timing trades in the stock. Another high-conviction bullish signal comes from Safety Insurance Group (SAFT), where a director with a previously perfect trade is doubling their total holdings. On the bearish side, consider the $58 million sale of Acadia Healthcare (ACHC) by Paulson & Co., as stocks this fund sells have historically dropped 28% within six months. The CEO of Applied Digital (APLD) also made their largest-ever sale after a 90% stock run-up, suggesting a belief that the stock may be peaking. Finally, insiders at The Oncology Institute (TOI) and Quantum Computing Inc. (QUBT) are taking significant profits after massive gains, signaling potential tops in those stocks.

Multiple insiders at The Cooper Companies ($COO), including the CEO, recently made significant stock purchases for the first time since 2020. The CEO's previous buys have historically led to a 16% return over the following three months, signaling strong bullish conviction. Conversely, a director at Trupanion ($TRUP) made a highly unusual $2.24 million unscheduled sale, which is a major bearish signal. The stock dropped 24% in the three months following this director's only other unscheduled sale. Lastly, a director at Safety Insurance Group ($SAFT) continues to show bullish conviction through repeated large purchases, with their last buy preceding a 25% gain over six months.

A massive $7.7 million insider buying cluster from the CEO and CIO at TriplePoint Venture Growth BDC Corp. (TPVG) signals a strong belief that the stock is undervalued. Similarly, Residio Technologies (REZI) is seeing consistent buying from a large institution and a director with a history of well-timed purchases, suggesting bullish conviction in the housing sector. Conversely, consider the significant insider selling at Frontier Group Holdings (ULCC) following its recent 50% price spike. These same insiders have an excellent track record of selling near market tops, indicating a potential reversal for the airline stock. Finally, a director at Liquidia Corporation (LQDA) made his first-ever sale of $19 million after a 200% run-up, suggesting he believes the stock is now fully valued.

Consider buying Eastman Chemical (EMN), where an unprecedented 11 insiders are purchasing shares for the first time in the company's history following a 25% stock decline. Another strong buy signal comes from Residio Technologies (REZI), as a director with an excellent track record just made a $1 million purchase after his previous buys preceded the stock doubling. Conversely, be cautious with Frontier Group Holdings (ULCC), where the CEO's recent large sale follows a historical pattern of the stock dropping 40% on average in the subsequent three months. Similarly, the CEO of Affirm Holdings (AFRM) initiating his first-ever selling plan is a major red flag, especially as a similar move by another executive in 2021 preceded a 90% stock collapse. These insider sales at ULCC and AFRM suggest leadership believes recent stock rallies are overextended.

A 10% owner of Diametica Therapeutics purchased over $11 million in stock around $6 per share, mirroring a past buy that led to the stock doubling. The CEO and CIO of Triple Point Venture Growth also showed strong conviction by collectively buying $7.7 million of their company's stock in the last few weeks. Conversely, the CEO of Frontier Group Holdings (ULCC) sold $3.55 million after a 50% rally; historically, his sales have preceded an average 40% drop within three months. Key executives at Par Pacific Holdings (PARR) are also selling after a 100% gain, and their last coordinated sale preceded a 60% stock decline. These significant insider sales in ULCC and PARR suggest caution is warranted after their recent sharp price increases.

Consider buying Resideo Technologies (REZI), as a director with an incredible track record of successful purchases has recently added to their position. Newly public Avidia Bancorp (AVBC) also presents a bullish opportunity, with eight different insiders conducting significant cluster buying since its IPO. A major red flag has appeared in Affirm Holdings (AFRM), where the CEO is selling shares for the first time ever and the CAO, who previously sold at the all-time peak, has also started a new selling plan. Similarly, investors should be cautious with Caterpillar (CAT) and Liquidia (LQDA), as key executives at both companies have recently made their first-ever stock sales after strong price increases. Finally, heavy insider selling clusters at Medpace (MEDP) and Carvana (CVNA) suggest leadership believes these stocks may be overvalued.

Consider Triple Point Venture Growth (TPVG), where multiple insiders, including a CEO with a strong track record, are consistently making large and increasing stock purchases. For a potential long-term investment, watch Summit Midstream Partners (SMLP), which is seeing its first-ever insider buys in company history after a 50% price decline. Investors holding Liquidity Services (LQDT) should be cautious, as insiders have sold a record $23 million in stock following its recent 72% price surge. Keep an eye on The Cooper Companies (COO), where executive buying after a 30% drop could signal a bottom, though the current signal is weaker than historical ones. Overall, corporate insiders are showing caution with low buying activity, suggesting a bearish short-term outlook for the broader market.